Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abasi Ene–Obong"'
Autor:
Arjun Biddanda, Karen Perez de Arce, Golibe Eze-Echesi, Chiamaka Nwuba, Yusuf Ibrahim, Olubukunola Oyedele, Esha Joshi, Boladale Alalade, Olanrewaju Ajayi, Chidimma Nwatu, Aminu Yakubu, Abasi Ene-Obong, Jumi Popoola, Colm O’Dushlaine, Peter Fekkes
Proteomic variation between individuals has immense potential for identifying novel drug targets and disease mechanisms. However, with high-throughput proteomic technologies still in their infancy, they have largely been applied in large majority Eur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa8c7b4063b6ade838ddf21c76496497
https://doi.org/10.1101/2022.12.09.519773
https://doi.org/10.1101/2022.12.09.519773
Autor:
Bill Gates, Jeantine Lunshof, Hakim Yadi, Luhan Yang, Tomas de Wouters, Sajith Wickramasekara, Xavier Duportet, Michelle Mc Murray Heath, Heather Dewey-Hagborg, Emily M LeProust, Jake Sherkow, Eddie Martucci, George M. Church, Arturo Elizondo, Teresa Tarragó, Neri Oxman, Leah V. Sibener, J. Craig Venter, Aviv Regev, Abasi Ene-Obong, Katrine Bosley, Francesco Gatto, Sebastian Giwa, Veronika Oudova, Sharon F. Terry, Silvia Gold, Spin Wang, Priscilla Chan, Jason Mellad, Christopher Thomas Scott, Charlotte Casebourn, Janice Chen, Sarah Richardson, Michael Chen, Bowen Zhao, Jeremy Farrar, Jernej Godec, John Cumbers
Publikováno v:
Nature Biotechnology, 39(6), 654-660. Nature Publishing Group
Nature Biotechnology asks a selection of leaders from across biotech to look at the future of the sector and make some predictions for the coming years.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfbf200877ba451ff54acacbe37f6aff
https://doi.org/10.1038/s41587-021-00941-4
https://doi.org/10.1038/s41587-021-00941-4
Autor:
Bill Gates, Charlotte Casebourn, Xavier Duportet, Sarah Richardson, Jake Sherkow, J. Craig Venter, Luhan Yang, Sajith Wickramasekara, Janice Chen, Aviv Regev, Sharon F. Terry, Tomas de Wouters, Abasi Ene-Obong, Heather Dewey-Hagborg, Jason Mellad, Eddie Martucci, Christopher Thomas Scott, Bowen Zhao, Arturo Elizondo, Francesco Gatto, Neri Oxman, Michael Chen, Veronika Oudova, Katrine Bosley, Emily M LeProust, Leah V. Sibener, Jernej Godec, Michelle Mc Murray Heath, Sebastian Giwa, John Cumbers, Hakim Yadi, Jeantine E. Lunshof, Jeremy Farrar, Silvia Gold, Spin Wang, Priscilla Chan, George M. Church, Teresa Tarragó
Publikováno v:
Nature Biotechnology. 39:1017-1017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6aab7a641fcde016d2a6a87d3d95a04
https://doi.org/10.1038/s41587-021-01000-8
https://doi.org/10.1038/s41587-021-01000-8
Autor:
Andrew Clear, Rewas Fatah, Claude Chelala, Jennifer Watt, John G. Gribben, Abasi Ene–Obong, Hemant M. Kocher, Jun Wang, John Riches, John Marshall, Jo-Anne Chin Aleong, Alan G. Ramsay
Publikováno v:
Gastroenterology. 145:1121-1132
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a prominent desmoplastic microenvironment that contains many different immune cells. Activated pancreatic stellate cells (PSCs) contribute to the desmoplasia. We investigated whether distinc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::423ee7bfff4b5c37ee756d0b607ba7ed
https://doi.org/10.1053/j.gastro.2013.07.025
https://doi.org/10.1053/j.gastro.2013.07.025
Publikováno v:
Pancreatology. 13:e10
s / Pancreatology 13 (2013) e1–e20 e10 vs. 79.1%). In HC, CP and PC, the combination of threemarkers (iC3b, ULBP2 and CA 19.9) has better predictive value than CA19.9 alone or combination of ULBP2 and CA19.9 or combination of iC3b and CA19.9 (79.6%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c90084d38c30b01c1abbce77bebfbef
https://doi.org/10.1016/j.pan.2012.12.030
https://doi.org/10.1016/j.pan.2012.12.030